PolyPeptide Group (Hangzhou): difference between revisions
Diff·revision 5 → 6·18:15, 20 Sep 2025
Difference between revision 5 and revision 6 of PolyPeptide Group (Hangzhou). 9 lines changed; the page grew by 2,396 bytes.
| Revision 5 — 08:54, 17 Sep 2025 eGFR_Esme (talk) state what the certificate supplied with orders carries 3,664 bytes +976 | Revision 6 — 18:15, 20 Sep 2025 COA_Colwyn (talk) add the research-use-only statement to the lead rather than only the footer 6,060 bytes +2,396 | ||
|---|---|---|---|
| 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} | 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} |
| 11 | 11 | ||
| + | 12 | This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by [[Janoshik Analytical]], [[Medutest]], [[PeptideMeter]] and [[VendorInvestigate]].{{r|tally}} | |
| + | 13 | ||
| 12 | == Corporate identity and history == | 14 | == Corporate identity and history == |
| 13 | Incorporated in Hangzhou in 2006, the organisation predates the current research-peptide market and describes a business built on [[Solid-phase peptide synthesis|solid-phase synthesis]] carried out on its own lines rather than on catalogue distribution.{{r|registry}} Hangzhou sits in the Yangtze River Delta manufacturing belt; the registry record establishes the entity and the date and nothing beyond them.{{r|registry}} | 15 | Incorporated in Hangzhou in 2006, the organisation predates the current research-peptide market and describes a business built on [[Solid-phase peptide synthesis|solid-phase synthesis]] carried out on its own lines rather than on catalogue distribution.{{r|registry}} Hangzhou sits in the Yangtze River Delta manufacturing belt; the registry record establishes the entity and the date and nothing beyond them.{{r|registry}} |
| ⋮ | ⋮ | ||
| 20 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. | 22 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. |
| 21 | 23 | ||
| + | 24 | == Operations and documentation practice == | |
| + | 25 | Purchaser reports describe vialled lyophilised material arriving with a batch-specific [[Certificate of analysis|certificate]] naming a [[Batch number|lot]], and across the submitted set the lot string on the certificate has corresponded to the vial label and to the commercial documentation.{{r|reports}} That correspondence is a minimum requirement rather than an achievement, and it is recorded only because [[Lot traceability|traceability]] fails often enough elsewhere in this sector to make its absence the more common finding. | |
| + | 26 | ||
| + | 27 | The feature that distinguishes the submitted certificates from others held by this wiki is the reproduction of the chromatogram itself. Where a certificate ordinarily reports an [[Area percent purity|area percent]] figure and asks the reader to accept it, the certificates in this set print the trace the figure was integrated from, with the gradient table, the column identifier and the detection wavelength beside it.{{r|reports}} A reader competent to read a chromatogram can therefore inspect baseline placement and integration limits rather than take the figure on trust. The limit of that is worth stating precisely: a printed trace evidences the integration of the injection it depicts. It does not establish that any particular vial was filled from the material that injection was drawn from, and no source available here bridges that gap.{{r|reports}} | |
| + | 28 | ||
| 22 | == References == | 29 | == References == |
| 23 | {{reflist}} | 30 | {{reflist}} |
| 24 | <ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref> | 31 | <ref name="registry">National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.</ref> |
| 25 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> | 32 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> |
| + | 33 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> | |
| + | 34 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | |
| 26 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 35 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 27 | 36 |